A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2002
12/12/2002	US20020187982 Glucagon antagonists/inverse agonists
12/12/2002	US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002	US20020187976 New benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
12/12/2002	US20020187973 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187970 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187969 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187968 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187967 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187966 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187965 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187964 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187963 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187962 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002	US20020187941 Pregabalin lactose conjugates
12/12/2002	US20020187939 Use of inhibitors of the renin-angiotensin system
12/12/2002	US20020187933 Cardiovascular disorders; regeneration of heart tissue
12/12/2002	US20020187930 Substances and their uses
12/12/2002	US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002	US20020187102 Novel compositions for use in embolizing blood vessels
12/12/2002	CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	CA2449482A1 Chds as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449393A1 Method for apo ciii measurement in apob and non apob containing particles
12/12/2002	CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449136A1 Igs as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449135A1 Adsls as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449077A1 Epothilone derivatives
12/12/2002	CA2449024A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
12/12/2002	CA2448828A1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448382A1 Use of hepcidin as a regulator of iron homeostasis
12/12/2002	CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2445460A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	CA2438099A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/11/2002	WO2002000231A1 Use of a formulation made of or containing at least one dissimilated milk serum
12/11/2002	WO2001083471A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264601A2 Treatment of a coronary condition by delivery of therapeutics to the pericardial space
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1264596A2 Use of a ferulic acid derivative as a preventive or remedy for hypertension
12/11/2002	EP1264183A2 Diagnosis and treatment of vascular dementia
12/11/2002	EP1263979A1 Method of purifying a fermentation broth
12/11/2002	EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263955A2 Polypeptides and nucleic acids encoding same
12/11/2002	EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/11/2002	EP1263953A2 Novel family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof
12/11/2002	EP1263943A1 Protein c derivatives
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263932A1 Embryonic stem cells and neural progenitor cells derived therefrom
12/11/2002	EP1263930A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263768A2 Chimeric neuropeptide y receptors
12/11/2002	EP1263767A2 Beta netrin and uses thereof
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263761A2 Compounds for pdt
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263758A2 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263753A1 Imidazol derivatives as raf kinase inhibitors
12/11/2002	EP1263740A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
12/11/2002	EP1263739A1 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
12/11/2002	EP1263737A1 2-phenylcarbamoyl-benzimidazoles
12/11/2002	EP1263736A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury
12/11/2002	EP1263733A2 Derivatives of quinoline as alpha-2 antagonists
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263504A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina
12/11/2002	EP1263484A1 Coating which promotes endothelial cell adherence
12/11/2002	EP1263470A1 METHOD FOR PRODUCING A COENZYME Q10 / $g(g)-CYCLODEXTRIN COMPLEX
12/11/2002	EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function
12/11/2002	EP1263455A2 Uses of bombesin receptor 3
12/11/2002	EP1263453A2 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
12/11/2002	EP1263452A2 Methods and compositions for generating angiostatin
12/11/2002	EP1263439A2 Sustained release ranolazine formulations
12/11/2002	EP1263434A1 Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1263414A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors
12/11/2002	EP1263300A1 Improvements in or relating to solubilisation of flavonols
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases

1 ... 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 ... 1595